Manuscripts
Showing 1596 manuscripts.
Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine The NIAID sponsored AIDS Vaccine Evaluation Group
Citation
John S. Lambert, M.D., Raphael P. Viscidi, M.D., MaryClare Walker, Ph.D., Barbara Clayman, Marcy Winget, Marcelo Wolff, M.D., David H. Schwartz, M.D., Ph.D. Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine The NIAID sponsored AIDS Vaccine Evaluation Group. Clinical and Diagnostic Laboratory Immunology. 1997 May 01; 4(3):302-8.Year
1997
Journal
Clinical and Diagnostic Laboratory Immunology
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS
Citation
Fred M. Gordin, M.D., John P. Matts, Ph.D., Carol Miller, M.P.H., Lawrence S. Brown, Jr., M.D., MPH, Richard Hafner, M.D., Stanley L. John, M.D., Marina B. Klein, M.D., C.M., M.Sc., Anita Vaughn, M.D., C. Lynn Besch, M.D., George Perez, M.D., Susan Szabo, M.D., Wafaa M. El-Sadr, M.D., M.P.H., M.P.A. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. New England Journal of Medicine. 1997 Jul 31; 337(5):315-20.Year
1997
Journal
New England Journal of Medicine
Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression.
Citation
David Charles Perlman, M.D., Wafaa M. El-Sadr, M.D., M.P.H., M.P.A., Eileen T. Denning, M.P.H., John P. Matts, Ph.D., Edward Elliot Telzak, M.D., Nadim Salomon, M.D., Keith D. Chirgwin, M.D., Richard Hafner, M.D. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clinical Infectious Diseases. 1997 Aug 01; 25(2):242-6.Year
1997
Journal
Clinical Infectious Diseases
Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1
Citation
L. M. Frenkel, D. E. Shapiro, D. H. Watts, B. Murante, S. Burchett, Y. J. Bryson, M. J. O'Sullivan, C. Mitchell. Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1. Journal of Infectious Diseases. 1997 Apr 01; 175:971-974.Year
1997
Journal
Journal of Infectious Diseases
Viral Load and Disease Progression In Infants Infected With Human Immunodeficiency Virus Type 1
Citation
William T. Shearer, Thomas C. Quinn, Philip LaRussa, Judy F. Lew, Lynne Mofenson, Susan Almay, Kenneth C. Rich, M.D., Edward Handelsman, M.D., Clemente Diaz, M.D., Marcello Pagano, Vincent Smeriglio, Leslie A. Kalish, M.D. Viral Load and Disease Progression In Infants Infected With Human Immunodeficiency Virus Type 1. New England Journal of Medicine. 1997 May 08; 336(19):1337-1342.Year
1997
Journal
New England Journal of Medicine
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals
Citation
J. M. Raboud, Julio S.G. Montaner, M.D., S. Rae, James O. Kahn, M.D., Scott M. Hammer, M.D., David Katzenstein, M.D., Andrew T. Pavia, M.D., Michael Hughes, Ph.D., Anne Cross, Ph.D., Mohan Beltangady, Ph.D., Jose M. Gatell Artigas, M.D., Ph.D., Lisa M. Dunkle, M.D., Laurie Smaldone, M.D. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antiviral Therapy. 1997 Dec 01; 2(4):237-47.Year
1997
Journal
Antiviral Therapy
Measuring quality of life in early HIV disease: the modular approach
Citation
William Lenderking, Ph.D., Marcia A. Testa, M.P.H., Ph.D., David Katzenstein, M.D., Scott M. Hammer, M.D. Measuring quality of life in early HIV disease: the modular approach. Quality of Life Research. 1997 Aug 01; 6(6):515-30.Year
1997
Journal
Quality of Life Research
Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing
Citation
Janet L. Lathey, Ph.D., Ian Marschner, Ph.D., William Kabat, B.S., Stephen A. Spector, M.D. Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing. Journal of Clinical Microbiology. 1997 Mar 01; 35(3):631-5.Year
1997
Journal
Journal of Clinical Microbiology
Molecular epidemiology of mucosal candidiasis in HIV-positive women
Citation
K. Dahl, Elizabeth Keath, Victoria J. Fraser, William G. Powderly, M.D. Molecular epidemiology of mucosal candidiasis in HIV-positive women. AIDS Research and Human Retroviruses. 1997 Apr 10; 13(6):485-91.Year
1997
Journal
AIDS Research and Human Retroviruses
Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their Newborns
Citation
Lambert JS, Mofenson LM, Fletcher CV, Moye J, Stiehm ER, Meyer WA, Nemo GJ, Mathieson BJ, Hirsch G, Sapan CV, Cummins LM, Jimenez E, O'Neill E, Kovacs A, Stek A. Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their Newborns. Journal of Infectious Diseases. 1997 Feb 01; 175:283-291.Year
1997
Journal
Journal of Infectious Diseases